Projected Earnings Date: 2025-02-06    (Delayed quote data   2025-01-06)
Last
 57.61
Change
 ⇑ +0.11   (+0.19%)
Volume
  316,765
Open
 57.39
High
 58.76
Low
 57.03
8EMA (Daily)
 56.62
40EMA (Daily)
 54.94
50EMA (Daily)
 54.14
STO (Daily)
 35.565
MACD Hist (Daily)
 -0.348
8EMA (Weekly)
 56.093
40EMA (Weekly)
 49.28
50EMA (Weekly)
 47.98
STO (Weekly)
 81.189
MACD Hist (Weekly)
 1.246
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Vericel has marketed products and the goal is to become the leader in cell therapy and regenerative medicine by developing, manufacturing and marketing best-in-class therapies for patients with significant unmet medical needs. The Company operates in one reportable segment: the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com